Transformation of Hematopoietic Cells and Activation of JAK2-V617F by IL-27R, a Component of a Heterodimeric Type I Cytokine Receptor

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0702388104
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Characterization of CD34+ Hematopoietic Progenitor Cells in JAK2 V617F and CALR -Mutated Myeloproliferative Neoplasms

Leukemia Research
Cancer ResearchOncologyHematology
2016English

A Novel Heterodimeric Cytokine Consisting of IL-17 and IL-17F Regulates Inflammatory Responses

Cell Research
Cell BiologyMolecular Biology
2007English

Effects of Deregulated Raf Activation on Integrin, Cytokine-Receptor Expression and the Induction of Apoptosis in Hematopoietic Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Concentration of Hematopoietic Progenitor Cells From Human Bone Marrow by a New Type of Blood Component Separator

Vox Sanguinis
MedicineHematology
1985English

Kinetic Study of Human Full-Length Wild-Type JAK2 and V617F Mutant Proteins

The Open Enzyme Inhibition Journal
2009English

JAK2-V617F-mediated Signalling Is Dependent on Lipid Rafts and Statins Inhibit JAK2-V617F-dependent Cell Growth

British Journal of Haematology
Hematology
2012English

Screening of JAK2 V617F Mutation in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

JAK2 V617F Hematopoietic Clones Are Present Several Years Prior to MPN Diagnosis and Follow Different Expansion Kinetics

Blood advances
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy